High Prevalence and Recent Increase in Multidrug-Resistant Helicobacter pylori in Bulgarian Patients: Pros and Cons of Culture-Based Susceptibility Testing
Authors:
- Lyudmila BoyanovaLyudmila Boyanova
- Liliya Yordanova BoyanovaLBLiliya Yordanova Boyanova
- Victor KamburovVKVictor Kamburov
- Vasil Svetoslavov BoyanovVasil Svetoslavov Boyanov
- Nikolay KatsarovNKNikolay Katsarov
- Nayden KandilarovNKNayden Kandilarov
- Jose MedeirosJMJose Medeiros
- Zoya SpassovaZSZoya Spassova
- Raina GergovaRGRaina Gergova
- Rumyana MarkovskaRMRumyana Markovska
Open Access
Abstract
We investigated the anti-Helicobacter pylori activity of five antibiotics against isolates from 226 symptomatic adult patients during two periods (2024–2026 and 2022–2023). Antibiotic susceptibility testing (AST) was performed by MIC test strips and/or a validated disk diffusion method for tetracycline. Overall resistance was 58.8% for metronidazole, 57.1% for clarithromycin, 41.2% for levofloxacin, 9.3% for amoxicillin, and 3.5% for tetracycline. Resistance rates to 1, 2, and 3–5 antibiotics (the latter defined as multidrug resistance, MDR) were 28.8%, 33.6%, and 23.9%, respectively. In 2024–2026, metronidazole and clarithromycin resistance prevalence exceeded 62%, and four patients/isolates had quadruple/quintuple resistance. In the second period, MDR rates were twice as high as in the first period, reaching 27.1% and 29.9%, respectively. Culture-based AST can detect resistance due to various mechanisms in H. pylori and determine exact (low or high) resistance levels. Briefly, we found high resistance rates to metronidazole, clarithromycin, levofloxacin, and MDR during the last few years, possibly due to high national antibiotic consumption. Phenotypic AST is useful for choosing individualized/tailored eradication regimens in treated patients in countries/regions with high H. pylori resistance/MDR. In the era of growing antibiotic resistance, culture-based AST is important and, therefore, should not be neglected.Keywords
Funding Information
- Medical University—Sofia (D-149/2025)
- Medical University—Sofia (9368/20.11.2024)
This publication has 43 references indexed in Scilit:
- Susceptibility-guided versus empirical therapy for Helicobacter pylori infection: a meta-analysis of randomized controlled trialsIndian Journal of Medical Microbiology, 2026
- Genomic determinants of antibiotic resistance for Helicobacter pylori treatment: a retrospective phenotypic and genotypic observational studyThe Lancet Microbe, 2025
- Whole genome sequence analysis of Helicobacter pylori isolates reveals incomplete characterization of antimicrobial resistance mechanismsiScience, 2025
- Delafloxacin and levofloxacin activities on Helicobacter pylori in Bulgaria over four yearsDiagnostic Microbiology and Infectious Disease, 2025
- Genomic insights into virulence, biofilm formation, and antimicrobial resistance of multidrug-resistant Helicobacter pylori strains of novel sequence types isolated from Vietnamese patients with gastric diseasesJournal of Global Antimicrobial Resistance, 2025
- The mechanisms of metronidazole resistance of Helicobacter pylori: A transcriptomic and biochemical studyMicrobial Pathogenesis, 2023
- Multiple amino acid substitutions in penicillin-binding protein-1A confer amoxicillin resistance in refractory Helicobacter pylori infectionJournal of Microbiology, Immunology and Infection, 2022
- Multidrug resistance: The clinical dilemma of refractory Helicobacter pylori infectionJournal of Microbiology, Immunology and Infection, 2021
- Antibiotics in treatment of COVID-19 complications: a review of frequency, indications, and efficacyJournal of Infection and Public Health, 2021
- Population-level macrolide consumption is associated with clarithromycin resistance in Helicobacter pylori: An ecological analysisInternational Journal of Infectious Diseases, 2019